Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katherine Gass

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
BMC Global and Public Health|May 31, 2025
Understanding the impact of covariates for trachoma prevalence prediction using geostatistical methodsMisaki Sasanami, Ibrahim Almou, Adam Nouhou Diori, et al.
Plos Neglected Tropical Diseases|November 15, 2021
Diagnostics to support elimination of lymphatic filariasis-Development of two target product profilesKimberly Y Won, Katherine Gass, Marco Biamonte, et al.
Tropical Medicine and Infectious Disease|February 26, 2026
Enablers of Post-Validation Surveillance for Lymphatic Filariasis in the Pacific Islands: A Nominal Group Technique and Expert ElicitationAdam T Craig, Clement Couteaux, Ken Jetton, et al.
Tropical Medicine and Infectious Disease|February 26, 2026
Integrated Approaches to Surveillance of Lymphatic Filariasis and Other Infectious Diseases in the Pacific IslandsAdam T Craig, Harriet L S Lawford, Temea Bauro, et al.
Plos Neglected Tropical Diseases|January 25, 2012
A multicenter evaluation of diagnostic tools to define endpoints for programs to eliminate bancroftian filariasisKatherine Gass, Madsen V E Beau de Rochars, Daniel Boakye, et al.
Plos Neglected Tropical Diseases|April 23, 2025
Guidance for conducting and evaluating serological surveys to assess interruption of yaws transmission in the context of an eradication targetOriol Mitjà, Katherine Gass, Michael Marks, et al.
Plos Neglected Tropical Diseases|December 17, 2013
Transmission assessment surveys (TAS) to define endpoints for lymphatic filariasis mass drug administration: a multicenter evaluationBrian K Chu, Michael Deming, Nana-Kwadwo Biritwum, et al.
International Health|August 26, 2025
Does persistent active trachoma mandate antibiotic mass drug administration? A comparison of prevalence of trachomatous inflammation-follicular with that of conjunctival infection and anti-chlamydial antibodies, Western Province, ZambiaConsity Mwale, Chileshe Mboni, Ngonda Saasa, et al.
BMJ Global Health|May 4, 2023
How well do coverage surveys and programmatically reported mass drug administration coverage match? Results from 214 mass drug administration campaigns in 15 countries, 2008-2017Kathryn L Zoerhoff, Pamela S Mbabazi, Katherine Gass, et al.
The American Journal of Tropical Medicine and Hygiene|July 31, 2025
Using Model-Based Geostatistics to Refine Population-Based Estimates of Trachoma Prevalence: Update from a Technical ConsultationAnna Harte, Misaki Sasanami, Clara R Burgert-Brucker, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
BMC Global and Public Health|May 31, 2025
Understanding the impact of covariates for trachoma prevalence prediction using geostatistical methodsMisaki Sasanami, Ibrahim Almou, Adam Nouhou Diori, et al.
Plos Neglected Tropical Diseases|November 15, 2021
Diagnostics to support elimination of lymphatic filariasis-Development of two target product profilesKimberly Y Won, Katherine Gass, Marco Biamonte, et al.
Tropical Medicine and Infectious Disease|February 26, 2026
Enablers of Post-Validation Surveillance for Lymphatic Filariasis in the Pacific Islands: A Nominal Group Technique and Expert ElicitationAdam T Craig, Clement Couteaux, Ken Jetton, et al.
Tropical Medicine and Infectious Disease|February 26, 2026
Integrated Approaches to Surveillance of Lymphatic Filariasis and Other Infectious Diseases in the Pacific IslandsAdam T Craig, Harriet L S Lawford, Temea Bauro, et al.
Plos Neglected Tropical Diseases|January 25, 2012
A multicenter evaluation of diagnostic tools to define endpoints for programs to eliminate bancroftian filariasisKatherine Gass, Madsen V E Beau de Rochars, Daniel Boakye, et al.
Plos Neglected Tropical Diseases|April 23, 2025
Guidance for conducting and evaluating serological surveys to assess interruption of yaws transmission in the context of an eradication targetOriol Mitjà, Katherine Gass, Michael Marks, et al.
Plos Neglected Tropical Diseases|December 17, 2013
Transmission assessment surveys (TAS) to define endpoints for lymphatic filariasis mass drug administration: a multicenter evaluationBrian K Chu, Michael Deming, Nana-Kwadwo Biritwum, et al.
International Health|August 26, 2025
Does persistent active trachoma mandate antibiotic mass drug administration? A comparison of prevalence of trachomatous inflammation-follicular with that of conjunctival infection and anti-chlamydial antibodies, Western Province, ZambiaConsity Mwale, Chileshe Mboni, Ngonda Saasa, et al.
BMJ Global Health|May 4, 2023
How well do coverage surveys and programmatically reported mass drug administration coverage match? Results from 214 mass drug administration campaigns in 15 countries, 2008-2017Kathryn L Zoerhoff, Pamela S Mbabazi, Katherine Gass, et al.
The American Journal of Tropical Medicine and Hygiene|July 31, 2025
Using Model-Based Geostatistics to Refine Population-Based Estimates of Trachoma Prevalence: Update from a Technical ConsultationAnna Harte, Misaki Sasanami, Clara R Burgert-Brucker, et al.
Pageof 6